T. Gnecchiruscone et al., EFFECTS OF ERGOTAMINE ON MYOCARDIAL BLOOD-FLOW IN MIGRAINEURS WITHOUTEVIDENCE OF ATHEROSCLEROTIC CORONARY-ARTERY DISEASE, The American journal of cardiology, 81(9), 1998, pp. 1165
The effects of intravenous ergotamine (0.25 mg) on basal and hyperemic
(dipyridamole) myocardial blood flow (MBF), measured with positron em
ission tomography and (H2O)-O-15, were assessed in 15 migraineurs in a
double-blind, randomized, placebo controlled, crossover study. Ergota
mine produced a 27% reduction in hyperemic MBF (2.62 +/- 0.11 vs 3.72
+/- 1.05 ml.min(-1).g(-1); p <0.05), a 31% reduction in the coronary v
asodilator reserve (1.81 +/- 0.50 vs 2.71 +/- 1.15; p <0.01), and a 55
% increase in minimal coronary resistance (42.2 +/- 15 vs 26.7 +/- 8 m
m Hg.min.ml(-1)g(-1); p <0.001), suggesting vasoconstriction of the co
ronary microcirculation.